AEON.WS
AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS
AEON.WS
Delisted
AEON.WS was delisted on the 26th of April, 2024.
40 hedge funds and large institutions have $623K invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
1
Calls
$25K
Puts
–
Net Calls
+$25K
Net Calls Change
-$35K
Top Buyers
| 1 |
SCM
1
Shaolin Capital Management
Miami,
Florida
|
$91.6K |
| 2 |
WAM
2
Wolverine Asset Management
Chicago,
Illinois
|
$8.71K |
| 3 |
3
Walleye Capital
New York
|
$4.87K |
| 4 |
4
Walleye Trading
New York
|
$1.96K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$67 |
